Fifty-nine percent of the patients had a prior CV event and 39% had documented coronary artery disease or other CV risk factors
European laboratories increasingly prefer blend formats to reduce handling variability and improve experimental consistency
Huang, J., Li, Y., Zhang, J., Liu, Y., & Lu, Q
By picking up Carmot and its three lead molecules which are all GLP-1 analogues and being tested in advanced stages of clinical trials Roche is on par with Novo Nordisk and Eli Lilly, the current leaders in the obesity drug space, according to analytics company GlobalData
[3] However, unlike pralmorelin (GHRP-2) and GHRP-6, but similarly to growth hormone-releasing hormone (GHRH), ipamorelin does not stimulate the secretion of adrenocorticotropic hormone (ACTH), or cortisol, and is highly selective for inducing the secretion only of GH